MANGANESE SUPEROXIDE DISMUTASE GENE POLYMORPHISM IS NOT ASSOCIATED WITH MYOCARDIAL INFARCTION IN SLOVENE TYPE 2 DIABETIC PATIENTS
DOI:
https://doi.org/10.5457/ams.v38i2.96Keywords:
MnSOD V16A gene polymorphism, myocardial infarction, diabetes mellitusAbstract
Aim: to investigate an association between the V16A MnSOD gene polymorphism and myocardial infarction (MI) in Slovene type 2 diabetic patients.
Patients and methods: in this case-control cross-sectional study a relationship between the alanine/valine single nucleotide polymorphism (SNP) at amino acid sequence 16 of manganese superoxide dismutase (Mn-SOD) gene and myocardial infarction (MI) in Slovene type 2 diabetic patients was evaluated.
Results: the V16A polymorphism of the Mn-SOD gene was analysed in 449 subjects with type 2 diabetes lasting more than 10 years: 159 with MI (diabetics with MI) and 290 diabetics with no history of CAD. The VV genotype of the V16A Mn-SOD SNP was not associated with MI in Slovene patients with type 2 diabetes (OR = 0.9; 95 % CI = 0.6-1.5; P = 0.7).
Conclusion: the V16A Mn-SOD SNP might not be used as a genetic marker for MI in Slovene type 2 diabetic patients.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
